世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5815
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ヤヌスキナーゼ（JAK）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）、用途別市場規模（自己免疫疾患、腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ヤヌスキナーゼ（JAK）阻害剤の市場動向
・企業の競争状況、市場シェア
・ヤヌスキナーゼ（JAK）阻害剤の種類別市場規模と予測2016-2027（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）
・ヤヌスキナーゼ（JAK）阻害剤の用途別市場規模と予測2016-2027（自己免疫疾患、腫瘍）
・ヤヌスキナーゼ（JAK）阻害剤の北米市場規模2016-2027（アメリカ、カナダ）
・ヤヌスキナーゼ（JAK）阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ヤヌスキナーゼ（JAK）阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ヤヌスキナーゼ（JAK）阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・ヤヌスキナーゼ（JAK）阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Astellas Pharma, Inc.、Eli Lilly and Co.、Incyte Corp.、Novartis AG、Pfizer Inc.）
・結論

JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy in the treatment of various chronic diseases.
The high unmet need for the treatment of graft-versus-host disease (GVHD) has also encouraged market vendors to develop novel drugs for GVHD. The lack of approved therapies for the treatment of rare cancer indications will also boost the demand for JAK inhibitors.

Market Analysis and Insights: Global Janus Kinase (JAK) Inhibitors Market
The global Janus Kinase (JAK) Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Janus Kinase (JAK) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Janus Kinase (JAK) Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Janus Kinase (JAK) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Janus Kinase (JAK) Inhibitors market.

Global Janus Kinase (JAK) Inhibitors Scope and Market Size
Janus Kinase (JAK) Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Janus Kinase (JAK) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ruxolitinib
Tofacitinib
Oclacitinib
Baricitinib
Peficitinib

Segment by Application
Autoimmune Disorders
Oncology

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astellas Pharma, Inc.
Eli Lilly and Co.
Incyte Corp.
Novartis AG
Pfizer Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ruxolitinib
1.2.3 Tofacitinib
1.2.4 Oclacitinib
1.2.5 Baricitinib
1.2.6 Peficitinib
1.3 Market by Application
1.3.1 Global Janus Kinase (JAK) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune Disorders
1.3.3 Oncology
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Janus Kinase (JAK) Inhibitors Market Perspective (2016-2027)
2.2 Janus Kinase (JAK) Inhibitors Growth Trends by Regions
2.2.1 Janus Kinase (JAK) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Janus Kinase (JAK) Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Janus Kinase (JAK) Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Janus Kinase (JAK) Inhibitors Industry Dynamic
2.3.1 Janus Kinase (JAK) Inhibitors Market Trends
2.3.2 Janus Kinase (JAK) Inhibitors Market Drivers
2.3.3 Janus Kinase (JAK) Inhibitors Market Challenges
2.3.4 Janus Kinase (JAK) Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Janus Kinase (JAK) Inhibitors Players by Revenue
3.1.1 Global Top Janus Kinase (JAK) Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Janus Kinase (JAK) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Janus Kinase (JAK) Inhibitors Revenue
3.4 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio
3.4.1 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Janus Kinase (JAK) Inhibitors Revenue in 2020
3.5 Janus Kinase (JAK) Inhibitors Key Players Head office and Area Served
3.6 Key Players Janus Kinase (JAK) Inhibitors Product Solution and Service
3.7 Date of Enter into Janus Kinase (JAK) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Janus Kinase (JAK) Inhibitors Breakdown Data by Type
4.1 Global Janus Kinase (JAK) Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Type (2022-2027)

5 Janus Kinase (JAK) Inhibitors Breakdown Data by Application
5.1 Global Janus Kinase (JAK) Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
6.2 North America Janus Kinase (JAK) Inhibitors Market Size by Type
6.2.1 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
6.3 North America Janus Kinase (JAK) Inhibitors Market Size by Application
6.3.1 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
6.4 North America Janus Kinase (JAK) Inhibitors Market Size by Country
6.4.1 North America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
7.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Type
7.2.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
7.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Application
7.3.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
7.4 Europe Janus Kinase (JAK) Inhibitors Market Size by Country
7.4.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type
8.2.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application
8.3.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region
8.4.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
9.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type
9.2.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application
9.3.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country
9.4.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type
10.2.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application
10.3.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country
10.4.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astellas Pharma, Inc.
11.1.1 Astellas Pharma, Inc. Company Details
11.1.2 Astellas Pharma, Inc. Business Overview
11.1.3 Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Introduction
11.1.4 Astellas Pharma, Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.1.5 Astellas Pharma, Inc. Recent Development
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Details
11.2.2 Eli Lilly and Co. Business Overview
11.2.3 Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Introduction
11.2.4 Eli Lilly and Co. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.2.5 Eli Lilly and Co. Recent Development
11.3 Incyte Corp.
11.3.1 Incyte Corp. Company Details
11.3.2 Incyte Corp. Business Overview
11.3.3 Incyte Corp. Janus Kinase (JAK) Inhibitors Introduction
11.3.4 Incyte Corp. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.3.5 Incyte Corp. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Janus Kinase (JAK) Inhibitors Introduction
11.4.4 Novartis AG Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Janus Kinase (JAK) Inhibitors Introduction
11.5.4 Pfizer Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ruxolitinib
Table 3. Key Players of Tofacitinib
Table 4. Key Players of Oclacitinib
Table 5. Key Players of Baricitinib
Table 6. Key Players of Peficitinib
Table 7. Global Janus Kinase (JAK) Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Janus Kinase (JAK) Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Janus Kinase (JAK) Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2016-2021)
Table 11. Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2022-2027)
Table 13. Janus Kinase (JAK) Inhibitors Market Trends
Table 14. Janus Kinase (JAK) Inhibitors Market Drivers
Table 15. Janus Kinase (JAK) Inhibitors Market Challenges
Table 16. Janus Kinase (JAK) Inhibitors Market Restraints
Table 17. Global Janus Kinase (JAK) Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Janus Kinase (JAK) Inhibitors Market Share by Players (2016-2021)
Table 19. Global Top Janus Kinase (JAK) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Janus Kinase (JAK) Inhibitors as of 2020)
Table 20. Ranking of Global Top Janus Kinase (JAK) Inhibitors Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Janus Kinase (JAK) Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Janus Kinase (JAK) Inhibitors Product Solution and Service
Table 24. Date of Enter into Janus Kinase (JAK) Inhibitors Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2016-2021)
Table 28. Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Janus Kinase (JAK) Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Application (2016-2021)
Table 32. Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 64. Astellas Pharma, Inc. Company Details
Table 65. Astellas Pharma, Inc. Business Overview
Table 66. Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Product
Table 67. Astellas Pharma, Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million)
Table 68. Astellas Pharma, Inc. Recent Development
Table 69. Eli Lilly and Co. Company Details
Table 70. Eli Lilly and Co. Business Overview
Table 71. Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Product
Table 72. Eli Lilly and Co. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million)
Table 73. Eli Lilly and Co. Recent Development
Table 74. Incyte Corp. Company Details
Table 75. Incyte Corp. Business Overview
Table 76. Incyte Corp. Janus Kinase (JAK) Inhibitors Product
Table 77. Incyte Corp. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million)
Table 78. Incyte Corp. Recent Development
Table 79. Novartis AG Company Details
Table 80. Novartis AG Business Overview
Table 81. Novartis AG Janus Kinase (JAK) Inhibitors Product
Table 82. Novartis AG Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million)
Table 83. Novartis AG Recent Development
Table 84. Pfizer Inc. Company Details
Table 85. Pfizer Inc. Business Overview
Table 86. Pfizer Inc. Janus Kinase (JAK) Inhibitors Product
Table 87. Pfizer Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million)
Table 88. Pfizer Inc. Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Janus Kinase (JAK) Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Ruxolitinib Features
Figure 3. Tofacitinib Features
Figure 4. Oclacitinib Features
Figure 5. Baricitinib Features
Figure 6. Peficitinib Features
Figure 7. Global Janus Kinase (JAK) Inhibitors Market Share by Application: 2020 VS 2027
Figure 8. Autoimmune Disorders Case Studies
Figure 9. Oncology Case Studies
Figure 10. Janus Kinase (JAK) Inhibitors Report Years Considered
Figure 11. Global Janus Kinase (JAK) Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Janus Kinase (JAK) Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Janus Kinase (JAK) Inhibitors Market Share by Regions: 2020 VS 2027
Figure 14. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2022-2027)
Figure 15. Global Janus Kinase (JAK) Inhibitors Market Share by Players in 2020
Figure 16. Global Top Janus Kinase (JAK) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Janus Kinase (JAK) Inhibitors as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Janus Kinase (JAK) Inhibitors Revenue in 2020
Figure 18. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2016-2021)
Figure 19. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2022-2027)
Figure 20. North America Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027)
Figure 22. North America Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027)
Figure 23. North America Janus Kinase (JAK) Inhibitors Market Share by Country (2016-2027)
Figure 24. United States Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027)
Figure 28. Europe Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027)
Figure 29. Europe Janus Kinase (JAK) Inhibitors Market Share by Country (2016-2027)
Figure 30. Germany Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Share by Region (2016-2027)
Figure 40. China Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027)
Figure 48. Latin America Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027)
Figure 49. Latin America Janus Kinase (JAK) Inhibitors Market Share by Country (2016-2027)
Figure 50. Mexico Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Share by Country (2016-2027)
Figure 56. Turkey Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Astellas Pharma, Inc. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021)
Figure 60. Eli Lilly and Co. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021)
Figure 61. Incyte Corp. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021)
Figure 63. Pfizer Inc. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界のヤヌスキナーゼ（JAK）阻害剤産業調査2019-2025

Global Janus Kinase (JAK) Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16247 2019年11月16日 117Pages
※本調査レポートでは、世界のヤヌスキナーゼ（JAK）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ヤヌスキナーゼ（JAK）阻害剤の種類別には、自己免疫疾患、腫瘍学に、用途別には、クリニック、病院に、地域別...

世界のヤヌスキナーゼ（JAK）阻害剤産業調査2019-2025

世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年）

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5949 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その...

世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年）

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場規模・現状・予測（2021年-2027年）

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5932 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オラパリブ、タラゾパリブ）、用途別市場規模（卵巣がん、乳がん、その他）、主要地域別市場規模（北米、アメリ...

世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年）

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-6061 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、血管内皮増殖因子（VEGF）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別市場規模（腫瘍、眼科）、主要地...

世界のHER2 (ヒト上皮成長因子受容体 2) 阻害剤市場規模・現状・予測（2021年-2027年）

Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-4306 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、HER2 (ヒト上皮成長因子受容体 2) 阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（乳がん、胃がん、卵巣がん、その他）、主要地域別市場規模（北米、アメ...

世界のプロテインキナーゼCイプシロン型市場規模・現状・予測（2021年-2027年）

Global Protein Kinase C Epsilon Type Market Size, Status and Forecast 2021-2027
QFJ1-5970 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、プロテインキナーゼCイプシロン型の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブリオスタチン-1、DHACP-6、VMD-1201、その他）、用途別市場規模（アルコール依存症、頭頸部がん、虚血性脳卒...

世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年）

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-5726 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、上皮成長因子受容体（EGFR）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、大腸がん、乳がん、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北...

世界のチロシンプロテインキナーゼ受容体TYRO3市場規模・現状・予測（2021年-2027年）

Global Tyrosine Protein Kinase Receptor TYRO3 Market Size, Status and Forecast 2021-2027
QFJ1-6057 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、チロシンプロテインキナーゼ受容体TYRO3の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RXDX-106、ELB-031、Q-701、その他）、用途別市場規模（膀胱がん、乳がん、転移性大腸がん、卵巣...

世界のヤヌスキナーゼ（JAK）阻害剤産業調査2019-2025 Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx milli…
世界のヤヌスキナーゼ（JAK）阻害剤産業調査2019-2025 Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx milli…
世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年） PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellular functions such as growth control, metabolism, and translation initiation. There is extensive ongoing research on targeted therapies such as PI3K inhibitors with proven efficacy in oncology applications…
がんヤヌスキナーゼ阻害剤のグローバル市場調査 2019年 The global Cancer Janus Kinase Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Janus Kinase Inhibitor volume and value at global level, regional level and company level. From a glob…
チロシンキナーゼJAK阻害剤のグローバル市場2021 Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. These inhibitors have therapeu…